Skip to main content
. 2024 Sep 18;13(18):5534. doi: 10.3390/jcm13185534

Figure 1.

Figure 1

Figure 1

Graphical representation of HAV seropositivity prevalence stratified for the male and female genders and total (male + female + total) in (a) 2015–2019, (b) 2020–2023, and (c) 2015–2023. The relative p-value and p-value trends in the (a) pre-pandemic and (b) pandemic periods are also reported. Z-scores in (c) represent the trend direction.